Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 186

1.

Obesity reduces the drug survival of second line biological drugs following a first TNF-α inhibitor in rheumatoid arthritis patients.

Iannone F, Fanizzi R, Notarnicola A, Scioscia C, Anelli MG, Lapadula G.

Joint Bone Spine. 2015 Jan 22. pii: S1297-319X(14)00280-2. doi: 10.1016/j.jbspin.2014.12.006. [Epub ahead of print]

PMID:
25619156
[PubMed - as supplied by publisher]
2.

Safety of Long Term Biologic Therapy in Rheumatologic Patients with a Previously Resolved HBV Infection.

Barone M, Notarnicola A, Lopalco G, Viggiani MT, Sebastiani F, Covelli M, Iannone F, Avolio AW, Di Leo A, Cantarini L, Lapadula G.

Hepatology. 2015 Jan 22. doi: 10.1002/hep.27716. [Epub ahead of print]

PMID:
25613809
[PubMed - as supplied by publisher]
3.

Two-year survival rates of anti-TNF-α therapy in psoriatic arthritis (PsA) patients with either polyarticular or oligoarticular PsA.

Iannone F, Lopriore S, Bucci R, Scioscia C, Anelli M, Notarnicola A, Lapadula G.

Scand J Rheumatol. 2015 Jan 7:1-8. [Epub ahead of print]

PMID:
25564882
[PubMed - as supplied by publisher]
4.

Bone and kidney toxicity induced by nucleotide analogues in patients affected by HBV-related chronic hepatitis: a longitudinal study.

Maggi P, Montinaro V, Leone A, Fasano M, Volpe A, Bellacosa C, Grattagliano V, Coladonato L, Lapadula G, Santantonio T, Angarano G.

J Antimicrob Chemother. 2014 Dec 18. pii: dku502. [Epub ahead of print]

PMID:
25525197
[PubMed - as supplied by publisher]
5.

Delights and let-downs in the management of tumor necrosis factor receptor-associated periodic syndrome: the canakinumab experience in a patient with a high-penetrance T50M TNFRSF1A variant.

Cantarini L, Lopalco G, Vitale A, Caso F, Lapadula G, Iannone F, Galeazzi M, Rigante D.

Int J Rheum Dis. 2014 Dec 18. doi: 10.1111/1756-185X.12521. [Epub ahead of print] No abstract available.

PMID:
25522898
[PubMed - as supplied by publisher]
6.

Retinal vessels thrombosis as onset manifestation of systemic sclerosis: 3 clinical cases.

Rotondo C, Lopalco G, Lapadula G, Iannone F.

J Rheumatol. 2014 Dec;41(12):2495-6. doi: 10.3899/jrheum.140624. No abstract available.

PMID:
25452188
[PubMed - in process]
7.

Position paper of Italian rheumatologists on the use of biosimilar drugs.

Atzeni F, Sebastiani M, Ricci C, Celano A, Gremese E, Iannone F, Meroni PL, Minghetti P, Sarzi-Puttini P, Ferraccioli G, Lapadula G.

Clin Exp Rheumatol. 2014 Nov 7. [Epub ahead of print]

PMID:
25436597
[PubMed - as supplied by publisher]
8.

Co-administration of ritonavir-boosted protease inhibitors and rate of tenofovir discontinuation in clinical practice.

Costarelli S, Cozzi-Lepri A, Lapadula G, Bonora S, Madeddu G, Maggiolo F, Antinori A, Gori A, D'Arminio-Monforte A.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19571. doi: 10.7448/IAS.17.4.19571. eCollection 2014.

PMID:
25394078
[PubMed - in process]
Free PMC Article
9.

The prevalence and predictive value of dipstick urine protein in HIV-positive persons in Europe.

Mocroft A, Ryom L, Lapadula G, Reiss P, Blaxhult A, Furrer H, Kutsyna G, Gatell J, Begovac J, Kirk O, Lundgren J.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19561. doi: 10.7448/IAS.17.4.19561. eCollection 2014.

PMID:
25394068
[PubMed - in process]
Free PMC Article
10.

Lipid profile of rheumatoid arthritis patients treated with anti-tumor necrosis factor-alpha drugs changes according to disease activity and predicts clinical response.

Cacciapaglia F, Anelli MG, Rinaldi A, Serafino L, Covelli M, Scioscia C, Iannone F, Lapadula G.

Drug Dev Res. 2014 Nov;75 Suppl 1:S77-80. doi: 10.1002/ddr.21203.

PMID:
25381986
[PubMed - in process]
11.

Correlation between serum levels of IL-15 and IL-17 in patients with idiopathic inflammatory myopathies.

Notarnicola A, Lapadula G, Natuzzi D, Lundberg I, Iannone F.

Scand J Rheumatol. 2014 Nov 7:1-5. [Epub ahead of print]

PMID:
25379698
[PubMed - as supplied by publisher]
12.

Possible interplay between interleukin-15 and interleukin-17 into the pathogenesis of idiopathic inflammatory myopathies.

Notarnicola A, Lapadula G, Natuzzi D, Iannone F.

Reumatismo. 2014 Nov 6;66(3):215-23. doi: 10.4081/reumatismo.2014.746.

PMID:
25376956
[PubMed - in process]
13.

Quality of life and unmet needs in patients with inflammatory arthropathies: results from the multicentre, observational RAPSODIA study.

Giacomelli R, Gorla R, Trotta F, Tirri R, Grassi W, Bazzichi L, Galeazzi M, Matucci-Cerinic M, Scarpa R, Cantini F, Gerli R, Lapadula G, Sinigaglia L, Ferraccioli G, Olivieri I, Ruscitti P, Sarzi-Puttini P.

Rheumatology (Oxford). 2014 Oct 6. pii: keu398. [Epub ahead of print]

PMID:
25288786
[PubMed - as supplied by publisher]
14.

Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's disease.

Cantarini L, Lopalco G, Caso F, Costa L, Iannone F, Lapadula G, Anelli MG, Franceschini R, Menicacci C, Galeazzi M, Selmi C, Rigante D.

Autoimmun Rev. 2015 Jan;14(1):1-9. doi: 10.1016/j.autrev.2014.08.008. Epub 2014 Aug 22.

PMID:
25151975
[PubMed - in process]
15.

Untangling the web of systemic autoinflammatory diseases.

Rigante D, Lopalco G, Vitale A, Lucherini OM, Caso F, De Clemente C, Molinaro F, Messina M, Costa L, Atteno M, Laghi-Pasini F, Lapadula G, Galeazzi M, Iannone F, Cantarini L.

Mediators Inflamm. 2014;2014:948154. doi: 10.1155/2014/948154. Epub 2014 Jul 15.

PMID:
25132737
[PubMed - in process]
Free PMC Article
16.

Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register.

Sebastiani M, Anelli MG, Atzeni F, Bazzani C, Farina I, Fedele AL, Favalli EG, Fineschi I, Cino N, Dal Forno I, Gasparini S, Cassarà E, Giardina R, Bruschi E, Addimanda O, Cassone G, Lopriore S, Sarzi-Puttini P, Filippini M, Pignatti F, Gremese E, Biggioggero M, Manganelli S, Amato G, Caimmi C, Salaffi F, Iannone F, Ferri C, Sandri G, Lapadula G, Gorla R, Govoni M, Ferraccioli G, Marchesoni A, Galeazzi M, Foti R, Carletto A, Cantini F, Triolo G, Epis OM, Salvarani C; Italian Study Group on Early Arthritides (GISEA).

Joint Bone Spine. 2014 Dec;81(6):508-12. doi: 10.1016/j.jbspin.2014.06.011. Epub 2014 Jul 28.

PMID:
25082646
[PubMed - in process]
17.

Epidural hematoma with detachment of the dural sinuses.

Lapadula G, Caporlingua F, Paolini S, Missori P, Domenicucci M.

J Neurosci Rural Pract. 2014 Apr;5(2):191-4. doi: 10.4103/0976-3147.131680.

PMID:
24966568
[PubMed]
Free PMC Article
18.

ECMO: an alternative support for acute respiratory failure caused by tuberculosis?

Cogliandro V, Lapadula G, Bandera A, Muscatello A, Marcolin R, Abbruzzese C, Rona R, Gori A.

Int J Tuberc Lung Dis. 2014 Jul;18(7):879-81. doi: 10.5588/ijtld.13.0752.

PMID:
24902570
[PubMed - in process]
19.

The adherence to ASAS classification criteria and to ASAS recommendations for the use of anti-TNH-alpha agents in axial spondyloarthritis.

Spadaro A, Lubrano E, Marchesoni A, Cauli A, Cantini F, Carotti M, D'Angelo S, Grassi W, Lapadula G, Macchioni P, Mathieu A, Punzi L, Ramonda R, Salaffi F, Salvarani C, Scarpa R, Olivieri I.

Clin Exp Rheumatol. 2014 Jul-Aug;32(4):465-70. Epub 2014 May 21.

PMID:
24850468
[PubMed - indexed for MEDLINE]
20.

Diagnosis of latent tuberculosis and prevention of reactivation in rheumatic patients receiving biologic therapy: international recommendations.

Iannone F, Cantini F, Lapadula G.

J Rheumatol Suppl. 2014 May;91:41-6. doi: 10.3899/jrheum.140101. Review.

PMID:
24788999
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk